BioOPS

Problem statement

Overcoming challenges for valorizing meat residues generated during slaughterhouse treatment like bovines and porcines by converting these into valuable products for application in the food, and biofertilizer industries.

Executive summary

BioOPS (Business Opportunities and challenges for meat co-products) is aDAFM funded project aiming at commercially exploring opportunities from low value streams (blood & lungs) in the meat sector (porcine & bovine). The goal is to assess pathways to improve economic and environmental sustainability in the meat sector

Value chain description

Ireland produces large numbers of bovine and porcine animals annually for the meat market, results in a large amount ofco-products generated. The two main coproducts which are chosen for valorization in BioOps are Blood and Lungs of the livestock because of their volume, applications and existing knowledge within Ireland. Assuming 3.2 L and 12L of blood produced per animal from porcine and bovine respectively it could result in the total generation of 10,372-ton (porcine) and 20,958-ton (bovine) blood per year. The whole blood can be directly heat processed to produce blood meal, or it can be centrifuged to produce RBC and plasma. The plasma fraction can then undergo hydrolysis to form bioactive peptide and can be fractionated to get thrombin, fibrinogen, globulin and BSA. RBC can undergo centrifugation to separate haemoglobin

Market deployment considerations

The global beef market size was valued at USD 467.7 billion in 2021 and is expected to progress at a compound annual growth rate (CAGR) of 4.8% from 2022 to 2030

Environmental considerations

Reducing waste and environmental footprint

Social Considerations

Generating revenue for beef farmers

Stakeholders Involved

Beef farmers, Technology producers, End users (pet food, pharmaceutical)

Feedstock used

Porcine, Bovine (Lungs, Blood)

TRL

2

Value Chain name

BiOrescue

Type of process

Blood processing (Centrifugation, Fractionation, hydrolysis, Heat processing)

Technology output

Blood meal, Bioactive peptides, Lungs (Collagen, Protein, Lung extraxt), Haemoglobulin, Plasma (Thrombin, Globulin, Fibrinogen, Bovine serum albumin) for potential use as fertiliser, animal feed, pet food, pharmaceutical(collagen) use

Processing capacity point of view (annual feedstock requirement)

NA

Country

Ireland

Year

2017